How to reduce 3-deoxyglucosone and acetaldehyde in peritoneal dialysis fluids

Peritoneal Dialysis International

Volumn 22, Issue 3, 2002, Pages 350-356

  Zimmeck, Thomas ^a   Tauer, Andreas ^a   Fuenfrocken, Michael ^a   Pischestrieder, Monika ^a  

^a F Med Care Deutschland GmbH   (Germany)

Author keywords

3 deoxyglucosone; Acetaldehyde; Chemical analysis; Glucose degradation products; Lactate buffer; Peritoneal dialysis fluids

Indexed keywords

3 DEOXYGLUCOSONE; ACETALDEHYDE; GLUCOSE; LACTIC ACID; MALIC ACID; PERITONEAL DIALYSIS FLUID; PROPIONALDEHYDE;

ARTICLE; CHEMICAL ANALYSIS; CHEMICAL PROCEDURES; CHEMICAL REACTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; METHODOLOGY; PERITONEAL DIALYSIS; PH; PRIORITY JOURNAL; TEMPERATURE;

EID: 0036587068     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080202200309     Document Type: Article

References (22)

1. Henderson I.S. Composition of peritoneal dialysis solution: potential hazards. Blood Purif 1989; 7:86-94.
2. Alobaidi HM, Coles GA, Davies M, Lloyd D. Host defence in continuous ambulatory peritoneal dialysis: the effect of the dialysate on phagocyte function. Nephrol Dial Ransplant 1986; 1:16-21.
3. Bronswijk H, Verbrugh HA, Bos HJ, Heezius ECJM, Oe PL, Meulen J, et al. Cytotoxic effects of commercial continuous ambulatory peritoneal dialysis (CAPD) fluids and of bacterial exoproducts on human mesothelial cells in vitro. Perit Dial Int 1989; 9:197-202.
4. Wieslander AP, Nordin MK, Kjellstrand PTT, Boberg UC. Toxicity of peritoneal dialysis fluids on cultured fibroblasts, L-929. Kidney Int 1991; 40:77-9.
5. Jörres A, Jörres D, Gahl GM, Kessel M, Müller C, Köttgen E, et al. Leukotriene B4 and tumor necrosis factor release from leukocytes: effect of peritoneal dialysate. Nephron 1991; 58:276-82.
6. Topley N, Mackenzie R, Petersen MM, Beavis MJ, Williams D, Thomas N, et al. In vitro testing of a potentially biocompatible continuous ambulatory peritoneal dialysis fluid. Nephrol Dial Transplant 1991; 6:574-81.
7. Wieslander AP, Nordin MK, Martinsson E, Kjellstrand PTT, Boberg UC. Heat sterilized PD fluids impair growth and inflammatory responses of cultured cell lines and human leukocytes. Clin Nephrol 1993; 39: 343-8.
8. Henderson IS, Couper IA, Lumsden A. Potentially irritant glucose metabolites in unused CAPD fluid. In: Maher JF, Winchester JF, eds. Frontiers in Peritoneal Dialysis. New York: Field Rich Assoc.; 1986: 261-4.
9. Witowski J, Korybalska K, Wisniewska J, Breborowicz A, Gahl GM, Frei U, et al. Effect of glucose degradation products on human peritoneal mesothelial cell function. JAm Soc Nephrol 2000; 11:729-39.
10. Nilsson-Thorell CB, Muscalu N, Andrén AHG, Kjellstrand PTT, Wieslander AP. Heat sterilization of fluids for peritoneal dialysis gives rise to aldehydes. Perit Dial Int 1993; 13:208-13.
11. Kjellstrand P, Martinson E, Wieslander A, Holmquist B. Development of toxic degradation products during heat sterilization of glucose-containing fluids for peritoneal dialysis: influence of time and temperature. Perit Dial Int 1995; 15:26-32.
12. Wieslander AP, Kjellstrand PTT, Rippe B. Heat sterilization of glucose-containing fluids for peritoneal dialysis: biological consequences of chemical alterations. Perit Dial Int 1995; 15(Suppl):S52-60.
13. Linden T, Forsbäck G, Deppisch R, Henle T, Wieslander A. 3-Deoxyglucosone, a promoter of advanced-glycation end products in fluids for peritoneal dialysis. Perit Dial Int 1998; 18:290-3.
14. Tauer A, Schmitt R, Knerr T, Schaub TP, Lage C, Passlick-Deetjen J, et al. Formation of the glucose degradation product 3-deoxyglucosone and other carbonyl compounds in single- and double-chamber bag PD fluids (Abstract). Perit Dial Int 2000; 20:142.
15. Lamb E, Cattell W, Dawnay A. In vitro formation of advanced glycation end products in peritoneal dialysis fluids. Kidney Int 1995; 47:1768-74.
16. Schalwijk C, Posthuma N, ten Brink H, ter Wee P, Teerlink T. Induction of 1,2-dicarbonyl compounds, intermediates in the formation of advanced glycation end-products, during heat-sterilization of glucose-based peritoneal dialysis fluids. Perit Dial Int 1999; 19: 325-33.
17. Tauer A, Knerr T, Niwa T, Schaub TP, Lage C, Passlick-Deetjen J, et al. In vitro formation of Nε-(carboxy-methyl)lysine and imidazolones under conditions similar to continuous ambulatory peritoneal dialysis (CAPD). Biochem Biophys Res Commun 2001; 280:1408-14.
18. Taylor RB, Joppy BM, Neil JM. Kinetics of dextrose degradation under autoclaving conditions. J Pharm Pharmacol 1972; 24:121-9.
19. Ledl F, Schleicher E. New aspects of the Maillard reaction in foods and in the human body. Angew Chem Int Ed Engl 1990; 29:565-94.
20. Madson M, Feather M. An improved preparation of 3-deoxy-d-erythro-hexos-2-ulose via the bis(benzoyl-hydrazone) and some related constitutional studies. Carbohydr Res 1981; 94:183-91.
21. Solutions for peritoneal dialysis. In: European Pharmacopoeia, 3rd ed. Strasbourg, France: Council of Europe; 1997: 1301-3.
22. Rice F, Fishbein L. Effect of aqueous sulfuric acid on sugars. II. Spectrometric studies on the hexoses; identification of ether-soluble products formed. J Am Chem Soc 1956; 78:3731-4.